Happy New Year! Towards the middle of 2019, South Korean President, Moon Jae In, has confirmed that biotechnology and biopharmaceutical industries in South Korea will be getting more funding to carry out all types of research and development along with manufacturing when it comes to creating vaccines, mAbs, and more treatments when it comes to health related applications. When it comes to patient health and prolonging the lives of the human population, it is important to know that your efforts and work ultimately work to help save and impact people in a positive way. This is promising news in the South Korean market as they work to grow their current industries and also help expand research to improve not just the country but also the biopharma/biotech industries itself!
RheoSense, Inc. works with two global partners in South Korea. If you would like to learn more information on our viscometer solutions or have questions on measuring viscosity, please click on the respective buttons to learn more about both of our partners, Sercrim Labtech and Insung Chromatech.
Some of our customers from South Korea have begun to actively particiate in requesting funding to help advance their research. Many have been conducting extensive research projects for many years already. The level of meticulous analysis and hard work has already been present for many years and it is exciting to see the country investing heavily into research and development!